Physician collaboration
The importance of collaboration
Learn more about how Medtronic aims to collaborate with physicians to drive innovation.
Our collaboration with physicians is vital to our efforts to create new or advance current therapies that transform lives and help us fulfill our Mission to alleviate pain, restore health, and extend lives. Physicians provide clinical insights, help us identify new avenues for therapy development, work with our researchers on technology development, and educate other physicians on the safe and effective use of our therapies.
When physicians provide these services, it’s appropriate to pay them fair market value while preserving the integrity of the physician-patient relationship. Fair market value is determined based on physician specialty and level of experience. Medtronic has established a fair market value for all of the ways we collaborate with physicians, which may vary based on geography, specialty, and level of physician experience.
At Medtronic, we take our ethical responsibilities seriously. We developed guiding principles for our physician collaborations to ensure that treatment decisions are driven by patient needs and physician expertise.
We have long supported transparency around consultant and intellectual property licensing payments to U.S. physicians — going back to 2010 where we were among the first companies to voluntarily report these payments to U.S. physicians on our website (see archive). Since that time, we have invested millions of dollars in building systems to comply with the tracking and reporting requirements of the Affordable Care Act (Sunshine legislation).
Our first revolutionary product — a wearable, battery-powered cardiac pacemaker developed in the 1950s — was the result of a close collaboration between Medtronic co-founder Earl Bakken and a pioneering heart surgeon at the University of Minnesota Medical School.
The medical technology industry relies on its ability to collaborate with physicians for three key reasons: